Parrish Capital
TEVA icon

Parrish Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Parrish Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-77,150
Closed -$2.61M – 88
2026
Q2 		$2.61M Sell
77,150
-20,003
-21% -$666K 2.52% 6
2026
Q1 		$2.93M Sell
97,153
-16,584
-15% -$534K 2.61% 4
2025
Q4 		$3.55M Buy
+113,737
New +$2.8M 3.21% 3

Other funds holding TEVA

Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Parrish Capital's TEVA Position: Q3 2026 in Review

Parrish Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 77,150 shares — an estimated $2.61M sold.

Parrish Capital first reported a position in TEVA in Q4 2025 and held it in 3 quarters. The position peaked at $3.55M in Q4 2025. 166 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Parrish Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • Parrish Capital sold 77,150 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $2.61M.
  • Parrish Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2025 and held it in 3 quarters.
  • Parrish Capital's Teva Pharmaceutical Industries Limited position peaked at $3.55M in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.